Clinical Trials Browser

Phase 1/2 × Small Cell Lung Carcinoma × PE regimen × Clear all

NCT04996771 2022-11-14

Surufatinib Combined With Chemotherapy Plus Toripalimab or Not in the Treatment of Small Cell Lung Cancer

Phase 1/2 Unknown

Small Cell Lung Carcinoma